Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
18.32 HKD | +0.77% | +1.33% | -8.40% |
Apr. 03 | Noah Holdings Grants Shares Under Employees Incentive Scheme | MT |
Mar. 27 | ADRs End Higher; Connect Biopharma Holdings Climbs 21% | DJ |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company shows low valuation levels, with an enterprise value at -1.15 times its sales.
- The company appears to be poorly valued given its net asset value.
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
Ratings chart - Surperformance
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.40% | 840M | - | ||
-6.22% | 113B | A- | ||
+20.42% | 63.85B | C | ||
+5.53% | 61.9B | - | B+ | |
+10.14% | 42.86B | C+ | ||
+9.61% | 40.84B | A- | ||
+18.75% | 34.58B | A- | ||
+4.08% | 25.46B | B | ||
-4.48% | 22.13B | A- | ||
+2.24% | 18.61B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- NOAH Stock
- 6686 Stock
- Ratings Noah Holdings Limited